Diagnostic value of melanoma inhibitory activity serum marker in the follow-up of patients with stage I or II cutaneous melanoma.

@article{Hofmann2009DiagnosticVO,
  title={Diagnostic value of melanoma inhibitory activity serum marker in the follow-up of patients with stage I or II cutaneous melanoma.},
  author={Maja Ann Hofmann and Felix Gussmann and Andreas Fritsche and Susanne E. Biesold and Bernd Schicke and Ingeborg Kuechler and Christiane A. Voit and Uwe Trefzer},
  journal={Melanoma research},
  year={2009},
  volume={19 1},
  pages={17-23}
}
In the follow-up of melanoma patients, there is still a need for an optimal serum marker to discover recurrent disease at an early stage. Melanoma inhibitory activity (MIA) has been investigated as a serum marker for cutaneous melanomas. Although the prognosis for melanoma based on stage is generally good, the disease identified at later stages is associated with high levels of morbidity and mortality. The value of MIA testing in early-stage melanoma was the goal of this study. Five thousand… CONTINUE READING
11 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Similar Papers

Loading similar papers…